phase readout
saveNCT07347600: A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: . Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that